A Phase III Study to Evaluate the Efficacy and Safety of Anti-IgE Monoclonal Antibody in Allergic Asthma Patients.
Condition: Asthma, Allergic Interventions: Drug: CMAB007; Drug: Symbicort; Drug: Seretide; Drug: Ventolin; Drug: placebo Sponsor: Shanghai Biomabs Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials